What is LumiraDx Limited (LMDX)?

LumiraDx Limited (LMDX) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of LMDX?

The current price of LMDX is $0.02. Prices are updated in real time on Stocks360.

What is LMDX's price-to-earnings (PE) ratio?

LMDX's trailing twelve-month PE ratio is -0.01, based on current price and earnings per share data available on Stocks360.

What is LMDX's market capitalization?

LMDX's market capitalization is $5,102,097.00, placing it in the small-cap tier.

LumiraDx Limited (LMDX)

Stock analysis · NASDAQ · Healthcare · Medical - Diagnostics & Research

$0.02

Market Cap

$5.10M

PE (TTM)

-0.01

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.71

Day Range

$0.02 – $0.03

52-wk Range

$0.02 – $0.03

Avg Volume

N/A

Volume

120.55M

LumiraDx Limited (LMDX) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $5.10M. Trailing PE -0.01. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Nov 8, 2023

EPS $-0.47 vs est. $-0.11

Missed by $0.36

Proprietary Signals

Signal snapshot temporarily unavailable.

About LumiraDx Limited

LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care. With approximately 30 tests either commercially available or under development, their comprehensive portfolio addresses critical conditions such as infectious diseases, cardiovascular disorders, diabetes, and coagulation issues. Furthermore, they offer a full suite of COVID-19 testing solutions, adaptable for both laboratory environments and immediate point-of-need applications. These diagnostic tools are widely adopted by governments and healthcare institutions, deployed in diverse settings including traditional laboratories, urgent care clinics, physician's offices, pharmacies, schools, and workplaces. Their applications span screening, diagnosis, and monitoring for both general wellness and specific diseases. Established in 2014, the company's headquarters are loc…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.01×
P/S (TTM)	0.02×
P/B	-0.04×
PEG	0.00×
P/FCF (TTM)	-0.03×
EV / EBITDA	-1.12×
EV / Sales	1.20×
Earnings Yield	-9947.02%
Free Cash Flow Yield	-3666.94%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$306.34M
Revenue (TTM)	$254.48M
Net Income (TTM)	-$507.51M
Free Cash Flow (TTM)	-$51.22M
Net Debt	$301.24M
Working Capital	$175.14M
Gross Margin	-13.87%
Operating Margin	-126.32%
Net Margin	-176.52%
Return on Equity	-1557.76%
Return on Invested Capital	-89.68%